Fresenius Medical Care (FMS) outlook: defensive dialysis demand, FME25+ cost savings boost margins, low valuation & strong ...

Fresenius Medical Care AG & Co. FMS entered 2026 with improving profitability, accelerating execution of its transformation ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The European Medicines Agency committee has recommended revoking the EU marketing authorisation for TAVNEOS®. This decision ...

FRANKFURT -Elliott Investment Management has taken a stake in Fresenius SE, a person familiar with the matter told Reuters on ...

Fresenius Kabi has received a warning letter related to the large-volume infusion pumps that it acquired through its $240 million takeover of Ivenix. The Food and Drug Administration sent the letter ...

View Fresenius Medical Care AG Sponsored ADR FMS stock quote prices, financial information, real-time forecasts, and company news from CNN.

Fresenius Medical Care Corporation (FMS) target price: $26.77 (15.1% upside). Current price: $23.25. See our analyst rating, ...

Fresenius Medical Care AG's FMS Q2 adjusted operating income increased 41% Y/Y to €401 million. The adjusted net income jumped 51% to €175 million. Revenue increased by 1% to €4.83 billion in the ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Fresenius Medical Care North America and Cigna have expanded their partnership for at least two years to provide members with end-stage renal disease access to more than 2,600 dialysis centers and ...

Shares in parent Fresenius drop to 2-year low FMC abandons 2025 targets CFO says some temp agencies lure nurses with $200/hour Medicare reimbursement increase may take 2 years July 28 (Reuters) - ...